{"id":"https://openalex.org/W3043082872","doi":"https://doi.org/10.3389/fonc.2020.01129","title":"Use of Allopurinol to Mitigate 6-Mercaptopurine Associated Gastrointestinal Toxicity in Acute Lymphoblastic Leukemia","display_name":"Use of Allopurinol to Mitigate 6-Mercaptopurine Associated Gastrointestinal Toxicity in Acute Lymphoblastic Leukemia","publication_year":2020,"publication_date":"2020-07-16","ids":{"openalex":"https://openalex.org/W3043082872","doi":"https://doi.org/10.3389/fonc.2020.01129","mag":"3043082872","pmid":"https://pubmed.ncbi.nlm.nih.gov/32766146","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7378397"},"language":"en","primary_location":{"id":"doi:10.3389/fonc.2020.01129","doi":"https://doi.org/10.3389/fonc.2020.01129","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2020.01129","pdf_url":"https://www.frontiersin.org/articles/10.3389/fonc.2020.01129/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/articles/10.3389/fonc.2020.01129/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Shannon E. Conneely","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]},{"id":"https://openalex.org/I4210147586","display_name":"Texas Children's Hospital","ror":"https://ror.org/05cz92x43","country_code":"US","type":"funder","lineage":["https://openalex.org/I4210147586"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shannon E. Conneely","raw_affiliation_strings":["Department of Pediatric Hematology and Oncology, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatric Hematology and Oncology, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, United States","institution_ids":["https://openalex.org/I181547552","https://openalex.org/I4210147586"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053691098","display_name":"Stacy Cooper","orcid":"https://orcid.org/0000-0001-8507-3732","observed_orcids":["https://orcid.org/0000-0001-8507-3732"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2799853436","display_name":"Johns Hopkins Medicine","ror":"https://ror.org/037zgn354","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stacy L. Cooper","raw_affiliation_strings":["Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, United States","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5036550103","display_name":"Rachel E. Rau","orcid":"https://orcid.org/0000-0003-4096-6603","observed_orcids":["https://orcid.org/0000-0003-4096-6603"]},"institutions":[{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]},{"id":"https://openalex.org/I4210147586","display_name":"Texas Children's Hospital","ror":"https://ror.org/05cz92x43","country_code":"US","type":"funder","lineage":["https://openalex.org/I4210147586"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Rachel E. Rau","raw_affiliation_strings":["Department of Pediatric Hematology and Oncology, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatric Hematology and Oncology, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, United States","institution_ids":["https://openalex.org/I181547552","https://openalex.org/I4210147586"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5036550103"],"corresponding_institution_ids":["https://openalex.org/I181547552","https://openalex.org/I4210147586"],"apc_list":{"value":2950,"currency":"USD","value_usd":2950},"apc_paid":{"value":2950,"currency":"USD","value_usd":2950},"fwci":0.5787,"has_fulltext":true,"cited_by_count":30,"citation_normalized_percentile":{"value":0.54237616,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":96,"max":98},"biblio":{"volume":"10","issue":null,"first_page":"1129","last_page":"1129"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/allopurinol","display_name":"allopurinol","score":0.9990000128746033},{"id":"https://openalex.org/keywords/6-mercaptopurine","display_name":"6-mercaptopurine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/acute-lymphoblastic-leukemia","display_name":"acute lymphoblastic leukemia","score":0.9620000123977661},{"id":"https://openalex.org/keywords/gastrointestinal-toxicity","display_name":"gastrointestinal toxicity","score":0.8889999985694885},{"id":"https://openalex.org/keywords/6-methylmercaptopurine","display_name":"6-methylmercaptopurine","score":0.824999988079071},{"id":"https://openalex.org/keywords/purine-metabolism","display_name":"purine metabolism","score":0.9150000214576721},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.8790000081062317},{"id":"https://openalex.org/keywords/myelosuppression","display_name":"myelosuppression","score":0.9210000038146973},{"id":"https://openalex.org/keywords/pediatric-leukemia","display_name":"pediatric leukemia","score":0.3869999945163727}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8647453784942627},{"id":"https://openalex.org/C2780261098","wikidata":"https://www.wikidata.org/wiki/Q412486","display_name":"Allopurinol","level":2,"score":0.8644174933433533},{"id":"https://openalex.org/C2777173762","wikidata":"https://www.wikidata.org/wiki/Q418529","display_name":"Mercaptopurine","level":2,"score":0.7590494751930237},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.5553156137466431},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.4787030518054962},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4515801668167114},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4485805630683899},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4403837025165558},{"id":"https://openalex.org/C2775967933","wikidata":"https://www.wikidata.org/wiki/Q1527888","display_name":"Pancreatitis","level":2,"score":0.43228480219841003},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.4297572374343872}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3389/fonc.2020.01129","doi":"https://doi.org/10.3389/fonc.2020.01129","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2020.01129","pdf_url":"https://www.frontiersin.org/articles/10.3389/fonc.2020.01129/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:7378397","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7378397","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Oncol","raw_type":"Text"},{"id":"pmid:32766146","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32766146","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in oncology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:8887f368ddcf4438a017d90b8299a1ed","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/8887f368ddcf4438a017d90b8299a1ed","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Oncology, Vol 10 (2020)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fonc.2020.01129","doi":"https://doi.org/10.3389/fonc.2020.01129","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2020.01129","pdf_url":"https://www.frontiersin.org/articles/10.3389/fonc.2020.01129/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3043082872.pdf","grobid_xml":"https://content.openalex.org/works/W3043082872.grobid-xml"},"referenced_works_count":37,"referenced_works":["https://openalex.org/W1267962195","https://openalex.org/W1568449544","https://openalex.org/W1801876107","https://openalex.org/W1881676016","https://openalex.org/W1968259751","https://openalex.org/W1971336136","https://openalex.org/W1983111442","https://openalex.org/W2003874138","https://openalex.org/W2016833582","https://openalex.org/W2017691879","https://openalex.org/W2044118975","https://openalex.org/W2057408299","https://openalex.org/W2064168827","https://openalex.org/W2093793436","https://openalex.org/W2096150129","https://openalex.org/W2109000403","https://openalex.org/W2118872779","https://openalex.org/W2120420315","https://openalex.org/W2145648574","https://openalex.org/W2149350612","https://openalex.org/W2157249349","https://openalex.org/W2175441911","https://openalex.org/W2178057047","https://openalex.org/W2333515270","https://openalex.org/W2464435466","https://openalex.org/W2597868456","https://openalex.org/W2791388988","https://openalex.org/W2793469548","https://openalex.org/W2794983932","https://openalex.org/W2900673338","https://openalex.org/W2905270347","https://openalex.org/W2907979520","https://openalex.org/W2914018879","https://openalex.org/W2969944130","https://openalex.org/W2995560246","https://openalex.org/W3043800854","https://openalex.org/W4323903801"],"related_works":["https://openalex.org/W3084591116","https://openalex.org/W3138123970","https://openalex.org/W2464435466","https://openalex.org/W2118872779","https://openalex.org/W4396573721","https://openalex.org/W2995560246","https://openalex.org/W4391824823","https://openalex.org/W2901318309","https://openalex.org/W4417016246","https://openalex.org/W4400559102"],"abstract_inverted_index":{"An":[0],"essential":[1],"component":[2],"of":[3,51,62,68,81,128,144,165],"acute":[4],"lymphoblastic":[5],"leukemia":[6],"(ALL)":[7],"therapy":[8,107,124,180],"is":[9,23,160,167],"the":[10,19,48,69,79],"prolonged":[11],"maintenance":[12,123],"phase":[13],"with":[14,100,116],"daily":[15],"6-mercaptopurine":[16],"(6-MP)":[17],"as":[18,34],"cornerstone.":[20],"While":[21],"6-MP":[22,63,85,121,131,166],"generally":[24],"well-tolerated,":[25],"some":[26],"patients":[27,138],"suffer":[28],"from":[29,59],"significant":[30],"side":[31,175],"effects":[32],"such":[33],"gastrointestinal":[35],"(GI)":[36],"toxicity,":[37],"including":[38],"hepatitis,":[39],"hypoglycemia,":[40],"nausea,":[41],"and":[42,87,108,151,173,185],"pancreatitis,":[43],"which":[44,140],"can":[45],"substantially":[46],"limit":[47],"tolerated":[49],"dose":[50,163],"6-MP.":[52],"These":[53],"toxicities":[54,118,133],"are":[55],"thought":[56],"to":[57,65,83,90,105,120,169,182],"result":[58],"skewed":[60],"metabolism":[61,86],"leading":[64],"an":[66,141],"accumulation":[67],"6-methylmercaptopurine":[70],"(6-MMP)":[71],"metabolite.":[72],"Here,":[73],"we":[74],"describe":[75],"current":[76],"knowledge":[77],"behind":[78],"use":[80,113],"allopurinol":[82,129,159],"modify":[84],"improve":[88],"tolerance":[89],"therapy.":[91],"This":[92],"method":[93],"has":[94,109,148],"been":[95,110,149],"successfully":[96],"used":[97],"in":[98,114,122,139],"adults":[99],"inflammatory":[101],"bowel":[102],"disease":[103],"refractory":[104],"purine":[106],"modified":[111],"for":[112,125,130,137,152],"children":[115],"GI":[117],"related":[119,132,174],"ALL.":[126],"Use":[127],"should":[134],"be":[135,183],"reserved":[136],"alternative":[142],"cause":[143],"signs":[145],"or":[146],"symptoms":[147],"excluded":[150],"whom":[153],"non-pharmacologic":[154],"measures":[155],"have":[156],"failed.":[157],"When":[158],"used,":[161],"simultaneous":[162],"reduction":[164],"required":[168],"avoid":[170],"severe":[171],"myelosuppression":[172],"effects,":[176],"though":[177],"overall":[178],"combination":[179],"appears":[181],"well-tolerated":[184],"effective":[186],"when":[187],"instituted":[188],"appropriately.":[189]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":4}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2020-07-23T00:00:00"}